semaglutide injection clinic shreveport As weight-loss drugs like Wegovy become common, Louisiana allows obesity treatment by telehealth bit.ly/3Qw2BF5 Louisiana has lifted a ban on treating the obesity via telehealth as GLP-1 drugs continue to revolutionize the Weight Management Services | Integrity

In Germany, heart failure is the leading cause for hospitalizations and a major driver of health care expenditure

This condition, called telogen effluvium, is triggered by the weight loss itself, not the specific medication

At the end of the 40-week study, participants taking retatrutide achieved an average A1C reduction of up to 2 percent

Research shows that stopping GLP-1 therapy often leads to regaining much of the lost weight, so ongoing, physician-led support is key for lasting results

This helps your body get used to the medicine

Before initiating XIGDUO XR in patients with one or more of these characteristics, assess volume status and renal function